FDA Approves of New Alzheimer’s Drug

The Food and Drug Administration recently announced accelerated approval of a new Alzheimer’s disease treatment developed by Biogen called Aduhelm.  Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003.  

Read more